With another inflammatory bowel disease (IBD) approval in the bag for Tremfya, Johnson & Johnson continues to make good on ...

Therapy with Skyrizi is 600mg given by infusion at weeks zero, four and eight, followed by a 360mg subcutaneous shot given at week 12 and every eight weeks thereafter. The FDA is also reviewing a ...

induction therapy to eliminate the need for in-clinic IV infusions required for Skyrizi and Omvoh. The ASTRO trial, whose full results will be revealed at ECCO 2025, has already demonstrated ...

The following biologics may be given by injection or infusion: Psoriasis can have serious health complications, including psoriatic arthritis, which affects the joints in up to 30% of people with ...